Found 14 results
Author Title [ Type(Desc)] Year
Filters: Author is Bird, AC  [Clear All Filters]
Journal Article
R. Mathew, Sivaprasad, S., Florea, D., Leung, I., Sallo, F., Clemons, T., Bird, A. C., and Peto, T., “Agreement Between Time-Domain and Spectral-Domain Optical Coherence Tomography in the Assessment of Macular Thickness in Patients with Idiopathic Macular Telangiectasia Type 2”, Ophthalmologica, vol. 230, pp. 144-150, 2013.
K. Balaskas, Leung, I., Sallo, F., Clemons, T., Bird, A. C., and Peto, T., “Associations Between Autofluorescence Abnormalities and Visual Acuity in Idiopathic Macular Telangiectasia Type 2: MacTel Project Report Number 5”, Retina, vol. 34, pp. 1630-1636, 2014.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M. J., and Harrington, M. W., “Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2”, Ophthalmic Epidemiol, vol. 17, no. 1, pp. 66-73, 2010.
I. Leung, Sallo, F. B., Bonelli, R., Clemons, T. E., Pauleikhoff, D., Chew, E. Y., Bird, A. C., and Peto, T., “Characteristics of Pigmented Lesions in Type 2 Idiopathic Macular Telangiectasia”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
E. Y. Chew, Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., Singerman, L., Schwartz, S. D., Peachey, N. S., and Bird, A. C., “Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial”, Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1., 2015.
F. B. Sallo, Peto, T., Egan, C., Wolf-Schnurrbusch, U. E., Clemons, T. E., Gillies, M. C., Pauleikhoff, D., Rubin, G. S., Chew, E. Y., and Bird, A. C., “"En Face" OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia”, Invest Ophthalmol Vis Sci, vol. 53, no. 10, pp. 6145-6152, 2012.
N. L. Parmalee, Schubert, C., Figueroa, M., Bird, A. C., Peto, T., Gillies, M. C., Bernstein, P. S., Kiryluk, K., Terwilliger, J. D., and Allikmets, R., “Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2”, PLoS One, vol. 7, no. 8, p. e24268, 2012.
M. Niskopoulou, Balaskas, K., Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., and Peto, T., “Is Indocyanine Green Angiography Useful for the Diagnosis of Macular Telangiectasia Type 2?”, Br J Ophthalmol, vol. 97, pp. 946-948, 2013.
F. B. Sallo, Peto, T., Egan, C., Wolf-Schnurrbusch, U. E., Clemons, T. E., Gillies, M. C., Pauleikhoff, D., Rubin, G. S., Chew, E. Y., and Bird, A. C., “The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia”, Invest Ophthalmol Vis Sci, vol. 53, no. 12, pp. 7889-7895, 2012.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Wang, J. J., Mitchell, P., Ramdas, W. D., and , “Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3”, Ophthalmic Epidemiol, vol. 20, pp. 109-113, 2013.
F. B. Sallo, Leung, I., Clemons, T. E., Peto, T., Bird, A. C., and Pauleikhoff, D., “Multimodal Imaging in Type 2 Idiopathic Macular Telangiectasia”, Retina, vol. 35, pp. 742-749, 2015.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M., and Harrington, M. W., “The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project”, Invest Ophthalmol Vis Sci, vol. 49, pp. 4340-4346, 2008.
T. F. Heeren, Clemons, T., Scholl, H. P., Bird, A. C., Holz, F. G., and P Issa, C., “Progression of Vision Loss in Macular Telangiectasia Type 2”, Invest Ophthalmol Vis Sci, vol. 56, pp. 3905-3912, 2015.
F. B. Sallo, Leung, I., Chung, M., Wolf-Schnurrbusch, U. E., Dubra, A., Williams, D. R., Clemons, T., Pauleikhoff, D., Bird, A. C., Peto, T., and Group, T. MacTel Stu, “Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia”, Opthalmology, vol. 118, no. 12, pp. 2461-2467, 2011.